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Background: A number of studies of genetic epidemiology have assessed the association of
C-589T (also referred to as C-590T; rs number, 2243250) polymorphisms in the promoter
region of interleukin-4 (IL-4) gene with asthma in different populations. However, the results
are inconsistent and inconclusive.
Objectives: We performed a meta-analysis of the association between C-589T polymorph-
isms of IL-4 and asthma with the following objectives: to estimate the magnitude of the
gene effect and the possible mode of inheritance.
Methods: A genetic model-free approach was used to perform a meta-analysis. Asthma
(atopy status nondeﬁned), nonatopic and atopic asthma subgroups were separately
analyzed. Heterogeneity and publication bias were also explored.
Results: Our meta-analysis summarized the evidence regarding the association between
C-589T polymorphisms in the promoter region of IL-4 gene and asthma. When all asthma
groups were pooled, a signiﬁcant association of increased asthma risk and T allele was
found. In subgroup analysis, our results indicated a signiﬁcant association and a recessive
genetic mode of C-589T polymorphisms of IL-4 with atopic asthma. The CC genotype was
about 21 percent less likely to have atopic asthma than the genotype CT and TT. However,
C-589T polymorphisms were not signiﬁcantly associated with nonatopic asthma.
Conclusions: This meta-analysis suggests there may be an important effect of single
nucleotide polymorphisms (SNPs) in the promoter region of IL-4 gene on the pathogenesis
of atopic asthma. This warrants further investigation in larger studies and meta-analysis.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
68752286; fax: +86 23 68752287.
m.cn (Y. Li).
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Interleukin-4 polymorphisms and asthma 985Introduction
Asthma is one of the most common respiratory diseases
caused by acute and chronic bronchial inﬂammation that
results in variable airway obstruction.1 As for etiology,
asthma is a complex genetic disease resulted from interac-
tions between multiple genes and environmental factors.2
IL-4 gene has been mapped to chromosome 5q31 where
asthma and atopy have also been linked.3 A number of
studies of genetic epidemiology have assessed the associa-
tion of C-589T (also referred to as C-590T, rs number
2243250) SNPs in the promoter region of IL-4 with asthma in
different populations.4–20 However, the results are incon-
sistent and inconclusive.
Population-based genetic epidemiology often seeks to
identify relatively small effects against a complex etiologi-
cal background. Because of this, most genetic association
studies tend to be statistically underpowered. Meta-analysis
allows using all the available published data to increase the
statistical power and identify causative genes with relia-
bility. In the meantime, there have been new developments
in the methodology of meta-analysis of genetic studies.21–23
A genetic model-free approach was suggested to the meta-
analysis of genetic association studies.22,23
We therefore used the genetic model-free approach to
perform a meta-analysis of the association between C-589T
polymorphisms of IL-4 and asthma with the following objectives:
to ascertain if there is an effect of these polymorphisms on
asthma susceptibility, and if so to estimate the magnitude of
that effect and the possible mode of inheritance.
Material and methods
Search strategy
Medline database (from January 1966 to November 2007)
was comprehensively searched using the ‘PubMed’ search
engine. Chinese Biomedical Literature database (CBM) was
searched (from January 1980 to November 2007) for studies
published in Chinese. The search strategy was the following.1. Asthma (MeSH)
2. Interleukin-4 (MeSH)
3. Genotype* or allele* or mutation* or variant* polymorph-
ism* (textword)
4. 1 and 2 and 3
Searching was performed in duplicate by two independent
reviewers (Y.L. and J.H.). Results were limited to English
language papers and Chinese language papers.
Inclusion criteria
Human studies, regardless of sample size, were included if
they met the following criteria:(1) IL-4 polymorphisms at C-589Tor C-590Twere determined.
(2) Studies were case-control design (retrospective or
nested case-control). The outcome was asthma (incident
or prevalent), and there were at least two comparisongroups, for example, asthma vs. control (nonasthma)
groups. Participants could be of any age. The design
based on family or sibling-pairs was excluded.(3) Each genotype frequency was reported, and there was
sufﬁcient information for extraction of data.Data extraction
Data were extracted independently and in duplicate by two
reviewers (Y.L. and J.H.) who used a standardized data
extraction form. Genotypes authors, journals years of publica-
tion, demographics, selection/characteristics of cases and
controls, and racial descent were extracted from each study.
Any disagreement was resolved by discussion and consensus.
Quality score assessment
The quality of studies was also independently assessed by the
two reviewers (Y.L. and J.H.) who used quality assessment
scores of molecular association studies of asthma recom-
mended by Thakkinstian et al.23 These scores were based on
both traditional epidemiologic considerations and genetic
issues.21 Total scores ranged from 0 (worst) to 15 (best). Any
disagreement was adjudicated by a third author (H.X.). Low
quality studies, quality score p4, were excluded.
Statistical analysis
First, all asthma groups were combined for meta-analysis.
The C and T alleles of C-589T variants were compared.
Separate analyses in dominant (genotype CC+CT vs. TT) and
recessive (genotype CC vs. CT+TT) genetic models were also
performed for the association with asthma.
Second, subgroups were analyzed based on asthma
deﬁnition: asthma (atopy status nondeﬁned); atopic asth-
ma; and nonatopic asthma. Genetic association, magnitude
and genetic model were tested by a genetic model-free
approach as described by Thakkinstian et al.22,23 Brieﬂy, the
process consists of the following steps:(1) Checking Hardy–Weinberg equilibrium (HWE): HWE was
checked only in the control groups using chi-square
goodness of ﬁt.(2) Checking heterogeneity: A test for heterogeneity was
performed separately for three odds ratios (ORs), that
is, CC vs. TT (OR1), CT vs. TT (OR2), and CC vs. CT (OR3)
for the C-589T polymorphisms.(3) Regression analysis: If there was no heterogeneity,
logistic regression analysis with the ﬁxed-effect model
was used to determine the gene effect; otherwise, the
random-effect model was used to pool. A likelihood ratio
(LR) test was used to gauge whether the overall gene
effect was signiﬁcant.(4) Determining the best genetic model: If the main effect
of the genotype was statistically signiﬁcant, further
comparisons of OR1, OR2, and OR3 were explored. These
pairwise differences were used to indicate the most
appropriate genetic model as follows: if OR1 ¼ OR36¼1
and OR2 ¼ 1, then a recessive model is suggested; if
OR1 ¼ OR26¼1 and OR3 ¼ 1, then a dominant model is
suggested; if OR2 ¼ 1/OR3 6¼1 and OR1 ¼ 1, then a
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Table 1 Characteristics of studies included in meta-analysis.
First author
(reference
no.)
Year Race Age (year) Female
(%)
Quality
score
Selection/characteristics of cases and controls Method of
evaluation of
atopic
phenotypey
Asthma cases Controls
Donfack 6 2005 Caucasian,
African
— — 7 Atopic/
nonatopic
zControls no personal and family history of
asthma
SPT
Cui8 2005 Chinese Range: 2–16 48 9 Atopic Healthy nonatopic controls with no history
of asthma and allergy, and from hospital
clinic
Total IgE/
speciﬁc IgE
Wang7 2004 Chinese Range: 17–72;
mean: 38
53 8 Asthma zHealthy controls with no history of asthma
and allergy, and from general population
SPT/total IgE
Cui5 2003 Chinese Mean: 41 47 8 Atopic zHealthy nonatopic controls with no history
of asthma and allergy
Speciﬁc IgE
Sandford4 2000 Caucasian Mean: 35.5 52 9 Atopic Nonatopic controls without astham SPT
Ådjers13 2005 Caucasian Range: 31–89;
mean: 60
63 9 Atopic/
nonatopic
zControls from general population,
matched for age, sex, area of residence
and race
SPT
Zhang15 2005 Chinese,
Malayan,
Hindoo
Mean: 42 48 6 Atopic/
nonatopic
zHealthy controls from blood donors Total IgE
Lee11 2004 Korean Mean: 11.2 42 10 Atopic/
nonatopic
Healthy nonatopic controls with no history
of asthma and allergy, from hospital clinic,
matched in age and sex
SPT/total IgE
Takabayashi14 2000 Japanese o18 43 6 Atopic Nonatopic controls from outpatients with
no history allergic diseases
SPT/total IgE
Hijazi12 2000 Arabs — — 6 Atopic/
nonatopic
zHealthy controls with no history of asthma
and atopy
SPT
Gervaziev17 2006 Caucasian Range: 17–65;
mean: 40.8
50 9 Asthma zHealthy control with no history of asthma
and allergic diseases
total IgE
Chiang19 2007 Chinese Mean of patients:
46; mean of
controls: 30
47 10 Asthma zHealthy control with no history of asthma
and allergic diseases
SPT
Hosseini-
Farahabadi18
2007 Caucasian Range: 18–62 — 9 Atopic zControls with no history of asthma and
allergy, matched in age and sex
SPT
Mak20 2007 Chinese Mean of patients:
43.7; mean of
controls: 42.4
50 10 Atopic/
nonatopic
zHealthy controls with no asthma, matched
in age and smoking status
SPT
‘‘—‘‘, no data.
Asthma, atopic status cannot be deﬁned; atopic, atopic asthma; nonatopic, nonatopic asthma.
ySPT, skin prick test to common aeroallergens; total IgE, increased total serum IgE levels; speciﬁc IgE, increased serum levels of IgE speciﬁc for common aeroallergens.
zControl subjects were not restricted by atopy status.
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Interleukin-4 polymorphisms and asthma 987complete overdominant model is suggested (also re-
ferred to as a ‘‘homozygous model’’ or ‘‘heterosis’’); if
OR14OR241 and OR14OR341 (or OR1oOR2o1 and
OR1oOR3o1), then a codominant model is suggested.(5) Pooling data: Once the best genetic model was
identiﬁed, this model was used to collapse the threere 1 Association of IL-4 C-589T polymorphims with asthma risk. F
s of OR and overall OR with 95% CI for IL-4 -589 allele C vs. T. (B)
otype CC vs. CT+TT. Black squares indicate the OR, with the size
zontal lines represent 95% CI. The pooled results are indicated by tgenotypes into two groups (except in the case of a
codominant model) and to pool the results again.Publication bias was assessed using the Egger test.24 All
analyses were performed using Stata 8.0 apart from logistic
regression analysis, for which Matlab 7.0 was used. A p-valuerom meta-analyses of data of all asthma groups: (A) Forest
Forest plots of OR and overall OR with 95% CI for IL-4 -589
of the square inversely proportional to its variance, and
he unshaded black diamond.
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Y. Li et al.988of less than 0.05 was considered statistically signiﬁcant,
except for tests of heterogeneity where a level of 0.10
was used.Figure 2 Estimation of the number of subjects needed to
detect signiﬁcant ORs for logistic regression analysis. For an
assumed genotype (CT+TT) frequency of 0.3 in the control
population, presented are estimations of power vs. number of
subjects per group needed to detect the indicated ORs of a
causal allele at a signiﬁcance level of 0.05, assuming no
genotyping errors, missing data, or population heterogeneity.Results
Medline and CBM database were comprehensively searched.
The possible relevant full papers were retrieved. We
identiﬁed 24 publications (including studies published in
Chinese) that had evaluated the association of C-589T or
C-590T polymorphisms with asthma. Ten studies were
excluded for the following reasons: sibling-paired and
family-based study design,25,26 no allele or genotyping
frequency, 27–29 repeat publication,30,31 and low quality
(quality scorep4).9,10,16 Fourteen studies were judged to
have met the inclusion criteria and provided complete data
in the paper.4–8,11–15,17–20 Total sample sizes for asthma and
control groups were 2476 and 2339, respectively. The
characteristics of the study populations were extracted
(Table 1).
When all asthma groups were combined for meta-analysis,
a statistically signiﬁcant association of increased asthma risk
and T allele, relative to the C allele (OR, 0.86; OR 95% CI,
0.78–0.94; p ¼ 0.002), was found (Figure 1A). The recessive
genetic model (genotype CC vs. genotype CT+TT) demon-
strated signiﬁcant association of the CT+TT genotype
with asthma (OR, 0.75; OR 95% CI, 0.64–0.89; p ¼ 0.001)
(Figure 1B). However, no signiﬁcant association was found in
dominant genetic model (genotype CC+CT vs. genotype TT;
OR, 0.89; OR 95% CI, 0.78–1.03; p ¼ 0.106).
We have estimated the number of subjects needed
to detect signiﬁcant ORs for logistic regression analysis
(Figure 2). For an assumed the average frequency of
subjects carrying at least one T allele (genotype ¼ CT or
TT) of 0.32 (estimated from the reports that met the
inclusion criteria) in the control population and a signiﬁ-
cance level of 0.05 with a power of 0.8, the number of
subjects per group is about 414 (unmatched case-control,
1:1) to detect signiﬁcant OR of 1.5. A bigger sample size is
needed to detect an OR of less than 1.5 with a power of 0.8
and a signiﬁcance level of 0.05 for association of asthma and
IL-4 C-589T genotype CT or TT.
Subgroups were analyzed based on asthma deﬁnition:
asthma (atopy status nondeﬁned); atopic asthma; and
nonatopic asthma. Genotype frequencies of the C-589T
polymorphism in different subgroups were provided in
Table 2. A genetic model-free approach was used to
evaluate the genetic models of subgroups.
As for atopic asthma subgroup, all studies, except one,20
in HWE were included in pooling. Results indicated hetero-
geneity for OR1 and OR3 but not for OR2 (Table 3). Logistic
regression with the random-effect model was used to assess
the overall gene effect. The overall gene effect was
signiﬁcant [LR test, w2 ¼ 7.10, p ¼ 0.03]. The estimated
OR1, OR2 and OR3 were 0.75, 1.00 and 0.76, respectively
(Table 3). These estimates suggest a recessive genetic
model, and therefore TT and CT were combined and
compared with CC. The pooled odds ratio was 0.79 (95%
CI: 0.64, 0.96, p ¼ 0.02) (Figure 3 and Table 3).
As for nonatopic asthma subgroup, the six studies
observing HWE were pooled.10,15–17,19,24 There was noheterogeneity for OR1, OR2 or OR3 (Table 3). Logistic
regression with the ﬁxed-effect model was used to assess
the overall gene effect, and the result was not signiﬁcance
level (w2 ¼ 0.07, p ¼ 0.97). The estimated OR1, OR2
and OR3 were 0.97, 1.01 and 0.96, respectively (Table 3).
These results suggest a recessive genetic model for
nonatopic asthma. However, the pooled odds ratio was not
signiﬁcant (OR, 0.96; p ¼ 0.80) in recessive model (Figure 3
and Table 3).Discussion
Our meta-analysis summarized the evidence to date
regarding the association between C-589T polymorphisms
and asthma, representing a pooled total of 2476 cases and
2339 controls, respectively. When all asthma groups were
pooled, a signiﬁcant association of increased asthma risk
and T allele was found. In subgroup analysis, our results
indicated a signiﬁcant association and a recessive genetic
mode of C-589T polymorphisms of IL-4 with atopic asthma.
The CC genotype was about 21 percent less likely to have
atopic asthma than the genotype CT and TT. Our results also
suggested C-589T polymorphisms were not signiﬁcantly
associated with nonatopic asthma.
For IL-4 C-589T, located in the promoter region of the IL-4
gene, it was shown T allele is associated with increasing of
the binding of a transcription factor.32,33 Therefore, it can
be hypothesized that this single nucleotide polymorphism
may lead to an overexpression of the IL-4 gene and thus
upregulate IL-4-dependent immunological reaction. In pre-
vious study,34,35 IL-4 was found to play a major role in
allergic disease, as it mediates Ig isotype switching from IgM
to IgE. Therefore, IL-4 is thought to be a direct participant in
the generation of high serum levels of IgE that are observed
in atopic individuals. However, the exact mechanisms how
ARTICLE IN PRESS
Table 2 Genotypes of the C-589T in asthma and controls of different subgroups.
Asthma group/study Asthma group Control group HWE
CC CT TT CC CT TT p-Value
Asthma
Gervaziev17 16 75 18 18 43 7 0.024
Chiang19 1 19 147 7 34 70 0.397
Wang7 29 42 22 21 26 15 0.303
Nonatopic asthma
Hijazi and Haider12 2 7 15 7 26 50 0.227
Donfack (Caucasian)6 30 12 2 144 55 6 0.798
Donfack (African)6 3 20 21 24 82 77 0.749
Lee11 4 19 37 3 29 68 1.000
Ådjers13 54 43 11 189 164 48 0.210
Mak20 6 30 9 57 104 0.823
Zhang (Chinese)15 0 14 38 1 17 46 1.000
Zhang (Malayan)15 1 6 9 6 16 19 0.486
Zhang (Hindoo)15 9 4 1 24 4 0 1.000
Atopic asthma
Hijazi and Haider12 3 18 39 2 5 10 0.525
Donfack (Caucasian)6 54 23 5 144 55 6 0.798
Donfack (African)6 21 62 77 24 82 77 0.749
Cui (2005)8 6 52 85 5 20 47 0.168
Takabayashi14 6 43 51 10 39 51 0.630
Lee11 5 58 131 3 29 68 1.000
Ådjers13 52 60 23 189 164 48 0.209
Cui5 5 37 56 4 32 67 1.000
Sandford4 146 78 9 100 41 2 0.528
Hosseini-Farahabadi 18 17 8 5 38 12 0 1.000
Zhang (Chinese)15 4 32 57 2 27 63 1.000
Zhang (Malayan)15 10 28 19 8 26 18 1.000
Zhang (Hindoo)15 39 27 5 38 26 7 0.393
Mak20 8 57 113 9 24 67 0.012
Hardy–Weinberg disequilibrium in control group.
Table 3 Determination of the genetic effects of C-589T polymorphisms on asthma.
Group/genotype Model-free approach (logistic regression) Heterogeneity test
Odds ratio 95% CI w2 p-Value
Atopic asthma
CC vs. TT 0.75 0.59, 0.95 60.69 0.000
CT vs. TT 1.00 0.82, 1.21 5.07 0.956
CC vs CT 0.76 0.62, 0.94 54.77 0.000
CC vs. CT+TT (recessive effect) 0.79 0.64, 0.96 6.93 0.862
Nonatopic asthma
CC vs. TT 0.97 0.67, 1.39 16.90 0.031
CT vs. TT 1.01 0.77, 1.33 7.45 0.489
CC vs. CT 0.96 0.70, 1.31 18.54 0.018
CC vs. CT+TT (recessive effect) 0.96 0.71, 1.30 6.44 0.598
Interleukin-4 polymorphisms and asthma 989these IL-4 polymorphisms affect atopic asthma risk at the
molecular level is still speculative. Further studies with
large population should be done to demonstrate the true
effect of C-589T polymorphisms on asthma.Attia et al.21 found that meta-analysis of population-
based molecular association studies have become increas-
ingly common over the last 10 years, but little attention has
been paid to methodology, particularly with regard to two
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Figure 3 Association of IL-4 C-589T polymorphisms with asthma in different sub-phenotypes. Forest plot shows OR and overall OR with 95% CI for -589 genotype CC vs. CT+TT in subgroups. Black
squares indicate the OR, with the size of the square inversely proportional to its variance, and horizontal lines represent 95% CI. The pooled results are indicated by the unshaded black diamond.
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Interleukin-4 polymorphisms and asthma 991issues: testing HWE, and pooling results in a manner that
reﬂects a biological model of gene effect. We used the
model-free approach to pool population-based molecular
association studies. This approach does not assume a priori
genetic model and avoids the problem of multiple compar-
isons.22 In addition, we calculated Hardy–Weinberg equili-
brium for all publications. The studies not in HWE were
excluded in pooling results.
There are several limitations that should be considered
when interpreting our results. Firstly, asthma itself is
heterogeneous and as such the divergent inclusion criteria
among patient groups might also lead to difﬁculties in
pooling the various studies. Secondly, the asthma phenotype
was often not fully speciﬁed in some studies, and details of
asthma diagnoses were often scanty. Thirdly, controls should
also be tested to screen out asthma and fully deﬁne the
topic status in the future studies.
Publication bias was not a major problem for this meta-
analysis study because most of the published studies
reported no signiﬁcant effects of the C-589T polymorphisms
on asthma risk. Signiﬁcance tests also did not suggest the
presence of publication bias for most studies (p ¼ 0.72).
Recently, Lau et al.36 doubted the widely used method of
funnel plot does not accurately predict publication bias. A
true standard measure of publication bias would require
prospective registries of studies with detailed knowledge of
which studies have been published and which are unpub-
lished. Given that efforts for study registration have only
recently started, this evaluation is currently difﬁcult.
To conclude, this may be the ﬁrst systematic and
comprehensive meta-analysis of C-589T polymorphisms in
IL-4 and asthma. A signiﬁcant recessive protective mode was
found in IL-4 C-589T polymorphisms with atopic asthma.
These results suggest the important effect of SNPs in the
promoter region of IL-4 gene on the pathogenesis of asthma.
This warrants further investigation in larger studies and
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